{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-234100","form_type":"8-K","ticker":"AMBA","cik":"0001280263","company_name":"AMBARELLA INC","filed_at":"2022-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.256590+00:00","generated_at":"2026-06-23T19:15:21.294905+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ambarella Q2 FY2023 revenue $80.9M (+2% YoY); GAAP EPS loss $0.62, non-GAAP EPS $0.20","bullets":["Revenue $80.9M, up 2% YoY from $79.3M; six-month revenue $171.2M, up 15% YoY.","GAAP net loss $23.7M ($0.62 loss per share) vs net loss $7.2M ($0.20) a year ago.","Non-GAAP net income $7.6M ($0.20 EPS), down from $13.1M ($0.35 EPS) in Q2 FY2022.","Cash & equivalents $197.9M, down from $449.2M a year ago after Oculii acquisition.","Q3 guidance: revenue $81-85M; non-GAAP gross margin 63-64%; CV5 processor entered mass production."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-234100","json":"https://secwatch.observer/filing/0001193125-22-234100.json","markdown":"https://secwatch.observer/filing/0001193125-22-234100.md","text":"https://secwatch.observer/filing/0001193125-22-234100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280263/000119312522234100/0001193125-22-234100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280263/000119312522234100/d355122d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T19:15:21.294905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}